Preservative exposure
Benzalkonium chloride remains in many generic glaucoma drops and is linked to irritation and inflammation of the surface.
Glaucoma Care · Ocular Surface
Long-term drop use and preservatives take a toll on the tear film, and a patient whose eyes burn is a patient who skips doses. Screening glaucoma patients for surface disease, and treating it, protects both comfort and pressure control.
Why it happens
Glaucoma patients are often older, use drops for years and frequently use more than one bottle, so several stresses on the tear film add up.
Benzalkonium chloride remains in many generic glaucoma drops and is linked to irritation and inflammation of the surface.
Surface disease tends to be worse in patients using more than one glaucoma medication each day.
Meibomian gland dysfunction, blepharitis, rosacea and allergy are common in the same age group and compound symptoms.
Burning and redness after instillation give patients a reason to skip doses, which undermines pressure control.
The aim is fewer preserved drops and a healthier surface, without giving up pressure control.
Preservative-free timolol, latanoprost, tafluprost and dorzolamide-timolol are available, as are drops with alternative preservatives.
Fixed combinations, selective laser trabeculoplasty or an intracameral implant can cut the number of daily drops.
Preservative-free artificial tears, lid hygiene, warm compresses and, where indicated, prescription anti-inflammatory dry eye drops.
Occlusion keeps tears on the eye but can also keep more glaucoma drug there, so weigh it against side effects.
In the clinic
Build a short surface check into the glaucoma follow-up rather than waiting for complaints.
Use a symptom questionnaire such as the OSDI and ask directly about burning and missed doses.
Check lid margins, meibomian glands, tear breakup and corneal and conjunctival staining at the slit lamp.
Change the formulation or regimen, start surface treatment, and recheck both pressure and comfort at the next visit.
| Preserved to preservative-free | Removes BAK exposure from the most-used bottle |
|---|---|
| Two bottles to a fixed combination | Halves the number of instillations for the same two classes |
| Drops to laser | SLT can reduce or replace drops for many patients |
| Drops to implant | Durysta or iDose TR deliver drug inside the eye for eligible patients |
| Add PF artificial tears | Supports the tear film between glaucoma doses |
Advise patients to wait at least five minutes between different eye drops so one does not wash out the next, and to use artificial tears separately from glaucoma doses.
In Leung and colleagues' study, 59% of glaucoma patients reported dry eye symptoms. Fechtner and colleagues found 48.4% of 630 patients had some degree of surface disease.
Not necessarily. Prioritize patients with symptoms, staining or several daily bottles, and those whose adherence is slipping.
Yes, spaced several minutes apart. Preservative-free tears avoid adding more preservative exposure.
They can improve tear volume, but they may also increase the amount of glaucoma drug that stays in contact with the eye. Use them with that trade-off in mind.
When surface disease or adherence limits medical therapy, laser trabeculoplasty, an implant or MIGS are options to discuss with the surgical partner.
Preservative-free tears, lid hygiene and heat masks are available at wholesale, and RescueLink lets you send them to patients between visits with a 15% participation credit on eligible OTC orders.
Stock preservative-free tears and lid care, and send them to glaucoma patients between visits with RescueLink.
Written for licensed eye care professionals. Treatment decisions remain with the treating doctor. Review each product's labeling before use. The RescueLink participation credit applies to eligible OTC orders on VisionRescue.com; contact lenses and prescriptions are excluded.